Propofol is an intravenous anaesthetic agent used for induction and maintenance of general anaesthesia. IV administration of propfol is used to induce unconsciousness after which anaesthesia may be maintained using a combination of medications. Recovery from propofol-induced anaesthesia is generally rapid and associated with less frequent side effects (e.g. drowsiness, nausea, vomiting) than with thiopental, methohexital, and etomidate. Propofol may be used prior to diagnostic procedures requiring anaesthesia, in the management of refractory status epilepticus, and for induction and/or maintenance of anaesthesia prior to and during surgeries.
Used for induction and/or maintenance of anaesthesia and for management of refractory status epilepticus.
Centre hospitalier universitaire de Liege, Liège, Belgium
Mansoura University, Mansoura, DK, Egypt
Cleveland Clinic, Cleveland, Ohio, United States
Peking University Hospital of Stomatology, Beijing, Beijing, China
The Six Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China
Faculty of medicine, Ain-Shams university, Cairo, Egypt
Beni-Suef University, Banī Suwayf, Egypt
Gaurav Sindwani, New Delhi, Delhi, India
UZ Brussel, Jette, Brussel, Belgium
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.